BIOMAT Database Logo BIOMAT Database Logo

Killed-measles-virus vaccine. 1967

V A Fulginiti, and C H Kempe

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles

Related Publications

V A Fulginiti, and C H Kempe
KILLED MEASLES-VIRUS VACCINE.
December 1963, New York state journal of medicine,
V A Fulginiti, and C H Kempe
Experience with measles immunization. Alum-absorbed killed measles-virus vaccine and live measles-virus vaccine challenge.
March 1962, American journal of diseases of children (1960),
V A Fulginiti, and C H Kempe
Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
January 1980, JAMA,
V A Fulginiti, and C H Kempe
Complicated measles after killed vaccine.
October 1970, Canadian Medical Association journal,
V A Fulginiti, and C H Kempe
MEASLES VACCINE: RESULTS OF STUDIES WITH BOTH KILLED AND LIVE VIRUS VACCINE.
July 1964, Memphis and Mid-South medical journal,
V A Fulginiti, and C H Kempe
Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.
August 1967, The New England journal of medicine,
V A Fulginiti, and C H Kempe
Atypical measles following immunization with killed measles vaccine.
October 1970, Canadian Medical Association journal,
V A Fulginiti, and C H Kempe
Epidemic measles. Modification by killed virus vaccine, given two years previously.
November 1965, The Journal of the College of General Practitioners,
V A Fulginiti, and C H Kempe
[Living attenuated measles-virus vaccine. VI. Results with a killed and living vaccine combination].
January 1965, Nihon Ika Daigaku zasshi,
V A Fulginiti, and C H Kempe
Vaccination against measles with Biken measles virus vaccine. Combined use of killed and live vaccines.
January 1966, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
Copied contents to your clipboard!